Stratos
Characteristic | Group 1 | Group 2 | Group 3 | |||||
Classification of |
|
|
|
|
|
|
| |
Atrial Fibrillation |
| N=42 |
| N=50 |
| N=24 | 0.537 | |
Persistent AF | 10 | (23.8%) | 17 (34%) | 6 (25%) | ||||
| ||||||||
Permanent AF | 32 | (76.2%) | 33 (66%) | 18 (75%) |
| |||
Classification of |
|
|
|
|
|
|
| |
Symptoms Related |
|
|
|
|
|
|
| |
to AF |
| N=42 |
| N=49 |
| N=25 |
| |
Palpitations | 32 | (76.2%) | 34 | (69.4%) | 14 | (56.0%) | 0.236 | |
Chest Pain | 6 (14.3%) | 7 (14.3%) | 3 (12.0%) | 1.000 | ||||
Dyspnea or shortness | 36 | (85.7%) | 40 | (81.6%) | 19 | (76.0%) | 0.568 | |
of breath | 34 | (81.0%) | 45 | (91.8%) | 18 | (72.0%) | 0.149 | |
Fatigue | ||||||||
Lightheadedness or | 17 | (40.5%) | 13 | (26.5%) | 9 (36.0%) | 0.329 | ||
syncope | 9 (21.4%) | 11 | (22.4%) | 10 | (40.0%) | 0.205 | ||
Other | ||||||||
|
|
|
|
|
|
| ||
Previous AF |
|
|
|
|
|
|
| |
Ablation |
| N=42 |
| N=50 |
| N=25 | 0.354 | |
No | 37 | (88.1%) | 47 | (94.0%) | 21 | (84.0%) | ||
| ||||||||
Yes | 5 (11.9%) | 3 | (6.0%) | 4 (16.0%) |
| |||
Past Medications |
|
|
|
|
|
|
| |
for Rate or Rhythm |
|
|
|
|
|
|
| |
Control |
|
|
|
|
|
|
| |
Amiodarone |
| N=41 |
| N=48 |
| N=24 |
| |
Digoxin |
|
|
| 0.192 | ||||
12 | (29.3%) | 10 | (20.8%) | 10 | (41.7%) | |||
Diltiazem | 17 | (41.5%) | 22 | (45.8%) | 13 | (54.2%) | 0.683 | |
Disopyramide | 17 | (41.5%) | 23 | (47.9%) | 12 | (50.0%) | 0.804 | |
Dofetilide | 0 | (0.0%) | 3 | (6.3%) | 0 | (0.0%) | 0.228 | |
Flecanide | 4 | (9.8%) | 3 | (6.3%) | 2 | (8.3%) | 0.895 | |
Ibutilide | 5 (12.2%) | 5 (10.4%) | 1 | (4.2%) | 0.656 | |||
Procainamide | 0 | (0.0%) | 0 | (0.0%) | 1 | (4.2%) | 0.215 | |
0 | (0.0%) | 2 | (4.2%) | 0 | (0.0%) | 0.506 | ||
Propafenone | ||||||||
2 | (4.9%) | 4 | (8.3%) | 0 | (0.0%) | 0.423 | ||
Sotolol | ||||||||
9 (22.0%) | 10 | (20.8%) | 2 | (8.3%) | 0.389 | |||
Verapamil | ||||||||
5 (12.2%) | 8 (16.7%) | 3 (12.5%) | 0.829 | |||||
Metoprolol | ||||||||
19 | (46.3%) | 28 | (58.3%) | 10(41.7%) | 0.382 | |||
Propranolol | ||||||||
0 | (0.0%) | 0 | (0.0%) | 1 | (4.2%) | 0.215 | ||
Other | 7 (17.1%) | 15 | (31.3%) | 4 (16.7%) | 0.248 | |||
Other Medications | 5 (12.2%) | 5 (10.4%) | 1 | (4.2%) | 0.656 |